Ontology type: schema:ScholarlyArticle
2016-10-24
AUTHORSR F Schlenk, F Stegelmann, A Reiter, E Jost, N Gattermann, H Hebart, C Waller, A Hochhaus, U Platzbecker, P Schafhausen, I W Blau, W Verbeek, F H Heidel, M Werner, H Kreipe, V Teleanu, A Benner, H Döhner, M Grießhammer, K Döhner
ABSTRACTMyeloproliferative neoplasm (MPN)-associated myelofibrosis is a MPN characterized by bone marrow fibrosis, cytopenias, splenomegaly and constitutional symptoms. Pomalidomide, an immune-modifying drug, is reported to improve anaemia and thrombocytopenia in some patients with MPN-associated myelofibrosis. We designed a phase 2 study of pomalidomide in patients with MPN-associated myelofibrosis and anaemia and/or thrombocytopenia and/or neutropenia. Subjects received pomalidomide 2.0 mg/day in cohort 1 (n=38) or 0.5 mg/day in cohort 2 (n=58). Prednisolone was added if there was no response after 3 months in cohort 1 and based on up-front randomization in cohort 2 if there was no response at 3 or 6 months. Response rates were 39% (95% confidence interval (CI), 26–55%) in cohort 1 and 24% (95% CI, 15–37%) in cohort 2. In a multivariable logistic regression model pomalidomide at 2.0 mg/day (odds ratio (OR), 2.62; 95% CI, 1.00–6.87; P=0.05) and mutated TET2 (OR, 5.07; 95% CI, 1.16–22.17; P=0.03) were significantly associated with responses. Median duration of responses was 13.0 months (range 0.9–52.7). There was no significant difference in response rates or duration in subjects receiving or not receiving prednisolone. Clinical trial MPNSG 01-09 is registered at ClinicalTrials.gov (NCT00949364) and clinicaltrialsregister.eu (EudraCT Number: 2009-010738-23) More... »
PAGES889-895
http://scigraph.springernature.com/pub.10.1038/leu.2016.299
DOIhttp://dx.doi.org/10.1038/leu.2016.299
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1025806578
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/27774990
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Alleles",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Chromosome Banding",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Immunologic Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mutation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Myeloproliferative Disorders",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Phenotype",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prednisolone",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Primary Myelofibrosis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Thalidomide",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "NCT Trial Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany",
"id": "http://www.grid.ac/institutes/grid.461742.2",
"name": [
"Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany",
"NCT Trial Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany"
],
"type": "Organization"
},
"familyName": "Schlenk",
"givenName": "R F",
"id": "sg:person.01100745713.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100745713.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany",
"id": "http://www.grid.ac/institutes/grid.410712.1",
"name": [
"Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany"
],
"type": "Organization"
},
"familyName": "Stegelmann",
"givenName": "F",
"id": "sg:person.01142076671.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142076671.13"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany",
"id": "http://www.grid.ac/institutes/grid.411778.c",
"name": [
"Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany"
],
"type": "Organization"
},
"familyName": "Reiter",
"givenName": "A",
"id": "sg:person.0655004216.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655004216.31"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine IV, University Hospital Aachen, Aachen, Germany",
"id": "http://www.grid.ac/institutes/grid.412301.5",
"name": [
"Department of Internal Medicine IV, University Hospital Aachen, Aachen, Germany"
],
"type": "Organization"
},
"familyName": "Jost",
"givenName": "E",
"id": "sg:person.01363705306.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01363705306.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany",
"id": "http://www.grid.ac/institutes/grid.14778.3d",
"name": [
"Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, D\u00fcsseldorf, Germany"
],
"type": "Organization"
},
"familyName": "Gattermann",
"givenName": "N",
"id": "sg:person.01273447501.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273447501.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Oncology, Stauferklinikum Mutlangen, Mutlangen, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Hematology and Oncology, Stauferklinikum Mutlangen, Mutlangen, Germany"
],
"type": "Organization"
},
"familyName": "Hebart",
"givenName": "H",
"id": "sg:person.0722500227.35",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722500227.35"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine I, University Hospital and Faculty of Medicine, University of Freiburg, Freiburg, Germany",
"id": "http://www.grid.ac/institutes/grid.5963.9",
"name": [
"Department of Internal Medicine I, University Hospital and Faculty of Medicine, University of Freiburg, Freiburg, Germany"
],
"type": "Organization"
},
"familyName": "Waller",
"givenName": "C",
"id": "sg:person.01060364644.81",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060364644.81"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Internal Medicine II, Jena University Hospital, Jena, Germany",
"id": "http://www.grid.ac/institutes/grid.275559.9",
"name": [
"Internal Medicine II, Jena University Hospital, Jena, Germany"
],
"type": "Organization"
},
"familyName": "Hochhaus",
"givenName": "A",
"id": "sg:person.01064615503.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064615503.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine I, University Hospital Dresden and GP Hematology and Oncology, Dresden, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Internal Medicine I, University Hospital Dresden and GP Hematology and Oncology, Dresden, Germany"
],
"type": "Organization"
},
"familyName": "Platzbecker",
"givenName": "U",
"id": "sg:person.0670313557.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670313557.25"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine II, University Hospital Hamburg, Hamburg, Germany",
"id": "http://www.grid.ac/institutes/grid.13648.38",
"name": [
"Department of Internal Medicine II, University Hospital Hamburg, Hamburg, Germany"
],
"type": "Organization"
},
"familyName": "Schafhausen",
"givenName": "P",
"id": "sg:person.01042737540.91",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042737540.91"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Hematology and Oncology, Charit\u00e9, Campus Benjamin Franklin, Berlin, Germany",
"id": "http://www.grid.ac/institutes/grid.6363.0",
"name": [
"Department of Hematology and Oncology, Charit\u00e9, Campus Benjamin Franklin, Berlin, Germany"
],
"type": "Organization"
},
"familyName": "Blau",
"givenName": "I W",
"id": "sg:person.01162304773.25",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162304773.25"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Center of Outpatient Hematology and Oncology, Bonn, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Center of Outpatient Hematology and Oncology, Bonn, Germany"
],
"type": "Organization"
},
"familyName": "Verbeek",
"givenName": "W",
"id": "sg:person.01153127421.50",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153127421.50"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "19Current address: Internal Medicine II, Jena University Hospital, Jena, Germany.",
"id": "http://www.grid.ac/institutes/grid.275559.9",
"name": [
"Department of Hematology and Oncology, University Hospital Magdeburg, Magdeburg, Germany",
"19Current address: Internal Medicine II, Jena University Hospital, Jena, Germany."
],
"type": "Organization"
},
"familyName": "Heidel",
"givenName": "F H",
"id": "sg:person.0775224107.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775224107.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pathology, University of Freiburg, Freiburg, Germany",
"id": "http://www.grid.ac/institutes/grid.5963.9",
"name": [
"Department of Pathology, University of Freiburg, Freiburg, Germany"
],
"type": "Organization"
},
"familyName": "Werner",
"givenName": "M",
"id": "sg:person.01170257101.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01170257101.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Pathology, Hannover Medical School, Hannover, Germany",
"id": "http://www.grid.ac/institutes/grid.10423.34",
"name": [
"Department of Pathology, Hannover Medical School, Hannover, Germany"
],
"type": "Organization"
},
"familyName": "Kreipe",
"givenName": "H",
"id": "sg:person.01233522012.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233522012.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany",
"id": "http://www.grid.ac/institutes/grid.410712.1",
"name": [
"Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany"
],
"type": "Organization"
},
"familyName": "Teleanu",
"givenName": "V",
"id": "sg:person.01015104603.78",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015104603.78"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany",
"id": "http://www.grid.ac/institutes/grid.7497.d",
"name": [
"Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany"
],
"type": "Organization"
},
"familyName": "Benner",
"givenName": "A",
"id": "sg:person.01366560070.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366560070.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany",
"id": "http://www.grid.ac/institutes/grid.410712.1",
"name": [
"Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany"
],
"type": "Organization"
},
"familyName": "D\u00f6hner",
"givenName": "H",
"id": "sg:person.01017653407.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017653407.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Oncology, Klinikum Minden, Minden, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Oncology, Klinikum Minden, Minden, Germany"
],
"type": "Organization"
},
"familyName": "Grie\u00dfhammer",
"givenName": "M",
"id": "sg:person.01330561767.84",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330561767.84"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany",
"id": "http://www.grid.ac/institutes/grid.410712.1",
"name": [
"Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany"
],
"type": "Organization"
},
"familyName": "D\u00f6hner",
"givenName": "K",
"id": "sg:person.01227023173.61",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227023173.61"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/ng.621",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045969373",
"https://doi.org/10.1038/ng.621"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrc1323",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044837763",
"https://doi.org/10.1038/nrc1323"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2011.77",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035556331",
"https://doi.org/10.1038/leu.2011.77"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2010.234",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034312502",
"https://doi.org/10.1038/leu.2010.234"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00262-008-0620-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000572951",
"https://doi.org/10.1007/s00262-008-0620-4"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.leu.2404914",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017755036",
"https://doi.org/10.1038/sj.leu.2404914"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature15252",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024476944",
"https://doi.org/10.1038/nature15252"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/leu.2010.254",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037260408",
"https://doi.org/10.1038/leu.2010.254"
],
"type": "CreativeWork"
}
],
"datePublished": "2016-10-24",
"datePublishedReg": "2016-10-24",
"description": "Myeloproliferative neoplasm (MPN)-associated myelofibrosis is a MPN characterized by bone marrow fibrosis, cytopenias, splenomegaly and constitutional symptoms. Pomalidomide, an immune-modifying drug, is reported to improve anaemia and thrombocytopenia in some patients with MPN-associated myelofibrosis. We designed a phase 2 study of pomalidomide in patients with MPN-associated myelofibrosis and anaemia and/or thrombocytopenia and/or neutropenia. Subjects received pomalidomide 2.0\u2009mg/day in cohort 1 (n=38) or 0.5\u2009mg/day in cohort 2 (n=58). Prednisolone was added if there was no response after 3 months in cohort 1 and based on up-front randomization in cohort 2 if there was no response at 3 or 6 months. Response rates were 39% (95% confidence interval (CI), 26\u201355%) in cohort 1 and 24% (95% CI, 15\u201337%) in cohort 2. In a multivariable logistic regression model pomalidomide at 2.0\u2009mg/day (odds ratio (OR), 2.62; 95% CI, 1.00\u20136.87; P=0.05) and mutated TET2 (OR, 5.07; 95% CI, 1.16\u201322.17; P=0.03) were significantly associated with responses. Median duration of responses was 13.0 months (range 0.9\u201352.7). There was no significant difference in response rates or duration in subjects receiving or not receiving prednisolone. Clinical trial MPNSG 01-09 is registered at ClinicalTrials.gov (NCT00949364) and clinicaltrialsregister.eu (EudraCT Number: 2009-010738-23)",
"genre": "article",
"id": "sg:pub.10.1038/leu.2016.299",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1097065",
"issn": [
"0887-6924",
"1476-5551"
],
"name": "Leukemia",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "31"
}
],
"keywords": [
"cohort 2",
"cohort 1",
"response rate",
"myeloproliferative neoplasms",
"phase 2 study",
"bone marrow fibrosis",
"immune-modifying drugs",
"constitutional symptoms",
"median duration",
"marrow fibrosis",
"myelofibrosis",
"pomalidomide",
"months",
"thrombocytopenia",
"prednisolone",
"significant differences",
"patients",
"anemia",
"neoplasms",
"days",
"duration",
"subjects",
"response",
"clinicaltrialsregister",
"cytopenias",
"neutropenia",
"splenomegaly",
"fibrosis",
"symptoms",
"drugs",
"randomization",
"TET2",
"MPN",
"rate",
"differences",
"study"
],
"name": "Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis",
"pagination": "889-895",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1025806578"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1038/leu.2016.299"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"27774990"
]
}
],
"sameAs": [
"https://doi.org/10.1038/leu.2016.299",
"https://app.dimensions.ai/details/publication/pub.1025806578"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:05",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_707.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1038/leu.2016.299"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/leu.2016.299'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/leu.2016.299'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/leu.2016.299'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/leu.2016.299'
This table displays all metadata directly associated to this object as RDF triples.
375 TRIPLES
21 PREDICATES
86 URIs
70 LITERALS
24 BLANK NODES